November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
August 29, 2014
RUSSIAN EMBASSY IN POLAND IS AWARE OF SITUATION WITH JET OF RUSSIAN DEFENSE MINISTER SHOIGU AND TRIES TO RESOLVE THE ISSUE ASAP IN CONTACT WITH POLISH AUTHORITIES - SPOKESPERSON
Results of Interregional Trading for OFZ & OBR
Capitalization of Russian stock market decreases 0.70% on Friday
Aggregated results for trading of shares in Moscow Exchange
Russian airlines transported more than 1 mln people to Crimes this summer
FESCO swings to IFRS net loss of 670 mln rubles in H1 (Part 3)
Dollar, euro continue growing on Moscow Exchange Friday
McDonald's closing 18 branches for few days in Sept to modernize
GAZ swings to IFRS net loss of 1.3 bln rubles in H1
Daily Headline News for August 29, 2014
Russia's proposal on temporary gas price unacceptable - Ukraine
Alrosa sees IFRS EBITDA fall 18% in Q2 to 21.27 bln rubles, below forecast
Lukoil's Fedun to recommend cutting $2 bln from capex (Part 3)